Cargando…

TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is one of the most common urological malignancies. Identifying novel biomarkers and investigating the underlying mechanism of ccRCC development will be crucial to the management and treatment of ccRCC in patients. Thymosin b10 (TMSB10), a member of the thymosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Qiufeng, Cheng, Gong, Liu, Yuenan, Xu, Tianbo, Zhang, Hao, Li, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115359/ https://www.ncbi.nlm.nih.gov/pubmed/32319572 http://dx.doi.org/10.3892/ijo.2020.4991

Ejemplares similares

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019)

METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

Overexpression of LINC00160 predicts poor outcome and promotes progression of clear cell renal cell carcinoma
por: Cheng, Gong, et al.
Publicado: (2020)

ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma
por: Pan, Qiufeng, et al.
Publicado: (2022)

Identification of a 5-Gene Signature Predicting Progression and Prognosis of Clear Cell Renal Cell Carcinoma
por: Pan, Qiufeng, et al.
Publicado: (2019)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
por: Xiong, Ye, et al.
Publicado: (2022)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
por: Wang, Qi, et al.
Publicado: (2021)

Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS/ERK pathway
por: Inoue, Miki, et al.
Publicado: (2022)

The immune infiltration in clear cell Renal Cell Carcinoma and their clinical implications: A study based on TCGA and GEO databases
por: Pan, Qiufeng, et al.
Publicado: (2020)

A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma
por: Liu, Mei, et al.
Publicado: (2020)

Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

TMSB4 Overexpression Enhances the Potency of Marrow Mesenchymal Stromal Cells for Myocardial Repair
por: Tang, Shiyuan, et al.
Publicado: (2021)

TMSB4X: A novel prognostic marker for non-small cell lung cancer
por: Yang, Ze, et al.
Publicado: (2023)

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Qu, Genyi, et al.
Publicado: (2022)

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2020)

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
por: Xu, Guang-hua, et al.
Publicado: (2018)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

The TMSB4 Pseudogene LncRNA Functions as a Competing Endogenous RNA to Promote Cartilage Degradation in Human Osteoarthritis
por: Liu, Qiang, et al.
Publicado: (2016)

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2019)

MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

DNMT1 maintains the methylation of miR‐152‐3p to regulate TMSB10 expression, thereby affecting the biological characteristics of colorectal cancer cells
por: Wang, Chenchen, et al.
Publicado: (2020)

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma
por: Tantawy, Marwa, et al.
Publicado: (2023)

ENO2 as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Shi, Jian, et al.
Publicado: (2023)

Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment
por: Wei, Xiyi, et al.
Publicado: (2021)

TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer
por: Wong, Hong Yuen, et al.
Publicado: (2015)

DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
por: Lee, Man-Gang, et al.
Publicado: (2022)

Changes in Biomechanical Properties of A375 Cells Due to the Silencing of TMSB4X Expression Are Not Directly Correlated with Alterations in Their Stemness Features
por: Makowiecka, Aleksandra, et al.
Publicado: (2021)

Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming
por: Wu, Yunjian, et al.
Publicado: (2022)

STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma
por: Zeng, Tao, et al.
Publicado: (2023)

AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis
por: Wang, Qi, et al.
Publicado: (2023)

High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
por: Ma, Wenliang, et al.
Publicado: (2022)

RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma
por: Chen, Weihao, et al.
Publicado: (2016)

Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis
por: Li, Yifan, et al.
Publicado: (2018)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma
por: Wu, Zonglong, et al.
Publicado: (2022)

Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression
por: Fan, Wen-Lang, et al.
Publicado: (2021)

Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro
por: Jiang, Huiming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j72rr9l1tnqb1f2q6fclhpc8r1